Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00503542 · ClinicalTrials.gov registry record · Early Phase 1
Management of Vaginal Complaints: A Pilot Study Within a Practice-Based Research Network
A Early Phase 1 study, sponsored by Agency for Healthcare Research and Quality (AHRQ).
- Completed
- Registry status
- Early Phase 1
- Development phase
- 46
- Enrollment target
NCT00503542: Completed Early Phase 1 study, sponsored by Agency for Healthcare Research and Quality (AHRQ).
NCT00503542 is a Early Phase 1 study that has completed, run by Agency for Healthcare Research and Quality (AHRQ). The registered enrollment target is 46 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (13% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00503542, a Early Phase 1 study, has completed, sponsored by Agency for Healthcare Research and Quality (AHRQ).
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 46 participants
- Enrollment target
Study Summary
Many women present in primary care with vaginal complaints. The best way of managing these complaints is unclear. This trial will test two different methods of managing patients with vaginal complaints. This is a pilot trial.
Interventions
- DRUG Terazol or oral fluconazole for candidal vaginitis
- DRUG Metronidazole or Clindamycin for Bacterial Vaginosis
- DRUG Flagyl for definitively diagnosed vaginal trichomoniasis
- OTHER Empiric Management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2007-02 |
| Est. Completion | 2008-02 |
| Phase | Early Phase 1 |
What the finished NCT00503542 record still lists
NCT00503542 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (13% lower).
The record links to 0 conditions, and to 4 interventions - of which Terazol or oral fluconazole for candidal vaginitis is the first listed.
NCT00503542 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00503542 about?
NCT00503542 is a clinical study titled "Management of Vaginal Complaints: A Pilot Study Within a Practice-Based Research Network". Many women present in primary care with vaginal complaints. The best way of managing these complaints is unclear. This trial will test two different methods of managing patients with vaginal complaints. This is a pilot trial.
What is the current status of trial NCT00503542?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 46 participants. The study started on 2007-02. Estimated completion is 2008-02.
What interventions are being tested in trial NCT00503542?
The interventions under investigation include: Terazol or oral fluconazole for candidal vaginitis (DRUG), Metronidazole or Clindamycin for Bacterial Vaginosis (DRUG), Flagyl for definitively diagnosed vaginal trichomoniasis (DRUG), Empiric Management (OTHER).
Who is sponsoring clinical trial NCT00503542?
This trial is sponsored by Agency for Healthcare Research and Quality (AHRQ), which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00503542's enrollment target sits among peer trials
46 566th of 2000 higher than 1,427 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia